Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Incidence and costs of adverse drug reactions in a tertiary care pediatric intensive care unit.

Du W, Tutag Lehr V, Caverly M, Kelm L, Reeves J, Lieh-Lai M.

J Clin Pharmacol. 2013 May;53(5):567-73. doi: 10.1002/jcph.75. Epub 2013 Mar 28.

PMID:
23553619
2.

Incidence and cost estimate of treating pediatric adverse drug reactions in Lagos, Nigeria.

Oshikoya KA, Chukwura H, Njokanma OF, Senbanjo IO, Ojo I.

Sao Paulo Med J. 2011 May;129(3):153-64.

3.

Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.

Lobo MG, Pinheiro SM, Castro JG, Momenté VG, Pranchevicius MC.

BMC Pharmacol Toxicol. 2013 Jan 8;14:5. doi: 10.1186/2050-6511-14-5.

4.
5.

Trends of adverse drug reactions related-hospitalizations in Spain (2001-2006).

Carrasco-Garrido P, de Andrés LA, Barrera VH, de Miguel GA, Jiménez-García R.

BMC Health Serv Res. 2010 Oct 13;10:287. doi: 10.1186/1472-6963-10-287.

6.

Prognostic factors in pediatric cancer patients admitted to the pediatric intensive care unit.

Dursun O, Hazar V, Karasu GT, Uygun V, Tosun O, Yesilipek A.

J Pediatr Hematol Oncol. 2009 Jul;31(7):481-4. doi: 10.1097/MPH.0b013e3181a330ef.

PMID:
19564740
7.

Creating opportunities for parent empowerment: program effects on the mental health/coping outcomes of critically ill young children and their mothers.

Melnyk BM, Alpert-Gillis L, Feinstein NF, Crean HF, Johnson J, Fairbanks E, Small L, Rubenstein J, Slota M, Corbo-Richert B.

Pediatrics. 2004 Jun;113(6):e597-607.

PMID:
15173543
8.

Evaluation of adverse drug reactions in medical intensive care units.

Park S, In Y, Suh GY, Sohn K, Kim E.

Eur J Clin Pharmacol. 2013 Jan;69(1):119-31. doi: 10.1007/s00228-012-1318-2. Epub 2012 Jun 7.

PMID:
22673928
9.

Respiratory syncytial virus morbidity, premorbid factors, seasonality, and implications for prophylaxis.

Hon KL, Leung TF, Cheng WY, Ko NM, Tang WK, Wong WW, Yeung WH, Chan PK.

J Crit Care. 2012 Oct;27(5):464-8. doi: 10.1016/j.jcrc.2011.12.001. Epub 2012 Jan 9.

PMID:
22227087
10.

Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.

Kunac DL, Kennedy J, Austin N, Reith D.

Paediatr Drugs. 2009;11(2):153-60. doi: 10.2165/00148581-200911020-00005.

PMID:
19301935
11.

Hospital costs of pediatric intensive care.

Chalom R, Raphaely RC, Costarino AT Jr.

Crit Care Med. 1999 Oct;27(10):2079-85.

PMID:
10548186
12.

Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability.

Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Bégaud B.

Eur J Clin Pharmacol. 2000 May;56(2):181-6.

PMID:
10877014
13.

Going back for more: an evaluation of clinical outcomes and characteristics of readmissions to a pediatric intensive care unit.

Odetola FO, Clark SJ, Dechert RE, Shanley TP.

Pediatr Crit Care Med. 2007 Jul;8(4):343-7; CEU quiz 357.

PMID:
17545926
14.

Mortality in very long-stay pediatric intensive care unit patients and incidence of withdrawal of treatment.

Naghib S, van der Starre C, Gischler SJ, Joosten KF, Tibboel D.

Intensive Care Med. 2010 Jan;36(1):131-6. doi: 10.1007/s00134-009-1693-z. Epub 2009 Oct 24.

PMID:
19855954
15.
16.

Consequences, measurement, and evaluation of the costs associated with adverse drug reactions among hospitalized patients in China.

Qing-ping S, Xiao-dong J, Feng D, Yan L, Mei-ling Y, Jin-xiu Z, Shu-qiang Z.

BMC Health Serv Res. 2014 Feb 17;14:73. doi: 10.1186/1472-6963-14-73.

17.

Serum creatinine as stratified in the RIFLE score for acute kidney injury is associated with mortality and length of stay for children in the pediatric intensive care unit.

Schneider J, Khemani R, Grushkin C, Bart R.

Crit Care Med. 2010 Mar;38(3):933-9. doi: 10.1097/CCM.0b013e3181cd12e1.

PMID:
20124891
18.

Management of oncology patients admitted to the paediatric intensive care unit of a general children's hospital - a single center analysis.

Haase R, Lieser U, Kramm C, Stiefel M, Vilser C, Bernig T, Merkel N, Mauz-Körholz C, Körholz D.

Klin Padiatr. 2011 May;223(3):142-6. doi: 10.1055/s-0031-1275291. Epub 2011 May 12.

PMID:
21567369
19.

Intensive care unit admission in children with malignant or nonmalignant disease: incidence, outcome, and prognostic factors: a single-center experience.

Faraci M, Bagnasco F, Giardino S, Conte M, Micalizzi C, Castagnola E, Lampugnani E, Moscatelli A, Franceschi A, Carcillo JA, Haupt R.

J Pediatr Hematol Oncol. 2014 Oct;36(7):e403-9. doi: 10.1097/MPH.0000000000000048.

PMID:
24276033
20.

Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005.

Patel H, Bell D, Molokhia M, Srishanmuganathan J, Patel M, Car J, Majeed A.

BMC Clin Pharmacol. 2007 Sep 25;7:9.

Supplemental Content

Support Center